Breast‐Cancer Diagnosis by Neuropeptide Y Analogues: From Synthesis to Clinical Application
Irfan Ullah Khan(Leipzig University), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences), Denise Zwanziger(Leipzig University), Ilka Böhme(Leipzig University), Muhammad Rizwan Javed(Government College University, Faisalabad), Syed Waqar Hyder(Institute of Radiotherapy and Nuclear Medicine), Hamid Naseer(Institute of Radiotherapy and Nuclear Medicine)
Cited by 82
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374